Ignite Creation Date:
2024-05-06 @ 3:47 PM
Last Modification Date:
2024-10-26 @ 1:57 PM
Study NCT ID:
NCT04757142
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-05
First Post:
2021-02-03
Brief Title:
PLASMA Chile PLASMA Chile
Sponsor:
Medtronic Cardiac Rhythm and Heart Failure
Organization:
Medtronic Cardiac Rhythm and Heart Failure
Study Overview
Official Title:
PLASMA Chile PLASMA Chile
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Prospective multicenter observational cohort study to collect data on Chilean patients diagnosed with Heart Failure with reduced ejection fraction their treatments and their progress in a real-world environment Additional objectives will be analyzed such as mortality and the barriers if any to receiving the indicated treatment
Detailed Description:
Identify the main epidemiological and clinical characteristics of patients with Heart Failure with reduced ejection fraction as well as the medical treatment models used
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None